The DOI matches its Crossref record; 131 of the 133 references it cites were found in a registry or an index.
Proton Magnetic Resonance Spectroscopy and Illness Stage in Schizophrenia—A Systematic Review and Meta-Analysis
Open accessAbstract
Background It is not known whether regional brain N-acetyl aspartate (NAA) changes in the progression from prodrome to chronic schizophrenia. We used effect size meta-analysis to determine which brain regions show the most robust reductions in NAA first episode and chronic schizophrenia as measured by proton magnetic resonance spectroscopy and to determine whether these changes are present in individuals at high risk of developing schizophrenia. Methods We identified 131 articles, of which 97 met inclusion criteria. Data were separated by stage of illness (at risk, first episode schizophrenia, chronic schizophrenia) and by brain region. For each region, mean and SD of the NAA measure was extracted. Results Significant reductions in NAA levels were found in frontal lobe, temporal lobe, and thalamus in both patient groups (effect size > .3; p < .01). In individuals at high risk of schizophrenia (of whom approximately 20% would be expected to undergo transition to psychosis), significant NAA reductions were present in thalamus (effect size = .78; p < .05), with reductions at trend level only in temporal lobe (effect size = .32; p < .1), and no reductions in frontal lobe (effect size = .05; p = .5). Conclusions These data suggest that schizophrenia is associated with loss of neuronal integrity in frontal and temporal cortices and in the thalamus and suggest that these changes in the frontal and temporal lobe might occur in the transition between the at-risk phase and the first episode.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“although it is worth noting that changes in cortical glutamate levels may vary with the age and treatment history of the patients 67 .”
From Developmental timing and critical windows for the treatment of psychiatric disorders (2016) · cites this paper as [67]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
A Simple Sequentially Rejective Multiple Test Procedure
(1979) · Scandinavian Journal of Statistics · doi:10.2307/4615733 · Cited by 21,526
Duval, S., & Tweedie, R. (2000) · Biometrics · doi:10.1111/j.0006-341x.2000.00455.x · Cited by 14,099
Gentleman R: R: A language for data analysis and graphics
Ihaka, R., & Gentleman, R. (1996) · Journal of Computational and Graphical Statistics · doi:10.1080/10618600.1996.10474713 · Cited by 11,747
J Neuropsychiatry Clin Neurosci
Yudofsky, S. C., & Hales, R. E. (1992) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.4.4.359 · Cited by 3,818
N-Acetylaspartate in the CNS: From neurodiagnostics to neurobiology
MOFFETT, J., Ross, B., Arun, P., Madhavarao, C. N., & Namboodiri, A. M. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.12.003 · Cited by 1,443
Pantelis, C., Velakoulis, D., McGorry, P. D., Wood, S. J., John Suckling, A., Phillips, L., Yung, A. R., Bullmore, E. T., Brewer, W. J., Soulsby, B., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12323-9 · Cited by 1,309
Lisman, J. E., Coyle, J. T., Green, R. W., Javitt, D. C., Benes, F. M., Heckers, S., & Grace, A. A. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.02.005 · Cited by 1,010
Research works printed but not linked: 2
- Venkatraman, 2006, Single-voxel 1H PRESS at 4.0 T: Precision and variability of measurements in anterior cingulate and hippocampus, NMR Biomed, 19, 484, 10.1002/nbm.1055 · DOI
- Steen, 2005, Measurement of brain metabolites by 1H magnetic resonance spectroscopy in patients with schizophrenia: A systematic review and Meta-analysis, Neuropsychopharmacology, 30, 1949, 10.1038/sj.npp.1300850 · DOI · Paper page
Cited by
Sorted by citations
Items 101–131 of 131
Applications of MRI in Schizophrenia: Current Progress in Establishing Clinical Utility
Sun, H. J., Liu, N., Qiu, C., Tao, B., Yang, C., Tang, B., Li, H., Zhan, K., Cai, C., Zhang, W., et al. (2024) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.29470 · Cited by 4
“34 Abnormal glutamate levels have been found in the early phase of schizophrenia and may underlie cognitive de fi - cits.”
Strzelecki, D., Grzelak, P., Podgórski, M. T., Kałużyńska, O., Stefańczyk, L., Kotlicka‐Antczak, M., & Gmitrowicz, A. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161024387 · Cited by 3
Taylor, M. J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-401688-0.00016-1 · Cited by 3
Zhang, J.-Z., Zhong, S.-M., Lai, S.-K., Zhang, Y.-L., Chen, G.-M., Huang, D., Yan, S.-Y., Chen, P., Lu, X.-D., Yin, J., et al. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.11.046 · Cited by 3
Bissonnette, J. N., Francis, A. M., MacNeil, S. E., Crocker, C. E., Tibbo, P. G., & Fisher, D. J. (2022) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2022.111459 · Cited by 2
The Relationship of glutamate signaling to cannabis use and schizophrenia
Niznikiewicz, M. A., Lin, A. P., & DeLisi, L. E. (2025) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000001003 · Cited by 3
Neuroimaging: Diagnostic Boundaries and Biomarkers
Galderisi, S., Giordano, G. M., & DeLisi, L. E. (2019) · Springer eBooks · doi:10.1007/978-3-319-97307-4_1 · Cited by 3
tDCS and Magnetic Resonance Imaging
Johnstone, A., Hinson, E. L., & Stagg, C. J. (2016) · Springer eBooks · doi:10.1007/978-3-319-33967-2_10 · Cited by 2
tDCS and Magnetic Resonance Imaging
Johnstone, A., Hinson, E. L., & Stagg, C. J. (2021) · Springer eBooks · doi:10.1007/978-3-030-76136-3_8 · Cited by 2
Mayeli, A., Janssen, S. A., Huston, C. A., Rupp, J. S., Sharma, K., Moon, C., Keihani, A., Hetherington, H. P., & Ferrarelli, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097682 · Cited by 2
“Few MRS studies have investigated NAA abnormalities in individuals at risk for psychosis; they found mostly negative results in the hippocampus and the anterior cingulate [14], and some significant or trend-level NAA reductions in the thalamus [12,25,26].”
BackgroundSmesny, S., Gussew, A., Schack, S., Langbein, K., Wagner, G., & Reichenbach, J. R. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.04.021 · Cited by 2
Glutamate, NAA, and energy metabolism in clinical high risk and first episode psychosis
King, B., Kempton, M. J., Man, S. K., Egerton, A., & Mizrahi, R. (2025) · Scientific Reports · doi:10.1038/s41598-025-22845-y · Cited by 1
Ätiopathogenetische Beiträge der Bildgebungsforschung in der Psychiatrie
Falkai, P., Schneider, F. W., Gründer, G., & Kambeitz, J. P. (2017) · Springer eBooks · doi:10.1007/978-3-662-49295-6_7 · Cited by 1
Markiewcz, R., Markiewicz, R., Kozioł, M. M., Szulecka, B., Olajossy, M., & Plech, T. (2019) · Psychiatria Polska · doi:10.12740/pp/onlinefirst/108491 · Cited by 1
Horská, A., & Mahone, E. M. (2012) · Springer eBooks · doi:10.1007/978-1-4419-5864-8_16 · Cited by 1
Capellán, R., Moreno, M., Orihuel, J., Roura‐Martínez, D., Ucha, M., Ambrosio, E., & Higuera‐Matas, A. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/641761 · Cited by 1
“The most consistent finding from 1H-MRS studies is the reduction in N-acetylaspartate levels that has been observed in the thalamus, as well as in the frontal and temporal lobes of schizophrenic patients (Brugger et al., 2011; Wijtenburg et al., 2015).”
BackgroundGotō, N., Yoshimura, R., Kakeda, S., Nishimura, J., Moriya, J., Hayashi, K., Hori, H., Ikenouchi, A., Umene‐Nakano, W., Katsuki, A., et al. (2011) · Clinical Neuropsychopharmacology and Therapeutics · doi:10.5234/cnpt.2.34
“Two oriented images (axial image and sagittal image) were used for each region because changes in NAA levels in those regions had been reported [4].”
BackgroundMethodSelective Review of Proton Magnetic Resonance Spectroscopy in Schizophrenia
Rao, N. P. (2014) · NOT FOUND REPOSITORY (Indian Institute of Science Bangalore)
Shendyapina, M., Omelchenko, M. A., Лебедева, И. С., Kanonovich, P. S., Semenova, N. A., Ublinskiy, M. V., Dmitrenko, D. M., Akhadov, T. A., Simonova, O. A., & Каледа, В. Г. (2015) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro20151151124-29
Shendyapina, M., Omelchenko, M. A., Лебедева, И. С., Kanonovich, P. S., Semenova, N. A., Ublinskiy, M. V., Dmitrenko, D. M., Akhadov, T. A., Simonova, O. A., & Каледа, В. Г. (2016) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-016-0271-4
Sleep Dysfunction in Adolescents at High Risk for Psychosis
Avery, J. R. L. (2014) · CU Scholar (University of Colorado Boulder)
A 1H-MRS and Neurocognitive Analysis of Psychotic Symptoms in Stimulant Dependence
Lakusta, B. (2012) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3q04w
Cognitive Neurophysiology and in vivo Neurochemistry of Bipolar Disorder
Ilhan, A. M. (2020) · Research Publications (Maastricht University) · doi:10.26481/dis.20200527ma
Ätiopathogenetische Beiträge der Bildgebungsforschung in der Psychiatrie
Falkai, P., Schneider, F. W., Gründer, G., & Kambeitz, J. P. (2017) · Springer eBooks · doi:10.1007/978-3-642-45028-0_7-2
Prior, M. J. W. (2012) · Royal Society of Chemistry eBooks · doi:10.1039/9781849734851-00348
Ätiopathogenetische Beiträge der Bildgebungsforschung in der Psychiatrie
Falkai, P., Schneider, F. W., Gründer, G., & Kambeitz, J. P. (2016) · Springer eBooks · doi:10.1007/978-3-642-45028-0_7-1
Magnetic Resonance Spectroscopy
Squarcina, L., & Brambilla, P. (2023) · Neuromethods · doi:10.1007/978-1-0716-3230-7_12
L’IRM pour la prise en soins des maladies psychiatriques
Mateos, M., Hanafi, R., Amad, A., Payva, M., Krystal, S., & Pruvo, J. (2023) · Journal d imagerie diagnostique et interventionnelle · doi:10.1016/j.jidi.2023.09.001
MORRIS, B. J. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05954-1 · Cited by 1
A Graph-Theoretical and MRS-Based Mathematical Model of Glutamatergic Dysfunction in Schizophrenia
Çevik, D. G. B., Analan, M. E., & Büyükköse, Ş. (2026) · Advances in Linear Algebra & Matrix Theory · doi:10.4236/alamt.2026.163003
Metadata
- Authors
- Brugger, S., Davis, J. M., Leucht, S., & Stone, J. M.
- Affiliations
- St George's, University of London (GB)
- University of Maryland, Baltimore (US)
- Technical University of Munich (DE)
- King's College London (GB)
- Corresponding author
- Stone, James M.
- Venue
- Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2011-03
- Volume
- 69
- Issue
- 5
- Pages
- 495-503
- ISSN
- 0006-3223 (ISSN-L)
- OpenAlex
- W1983956215
- Cited by
- 131
- References
- 133
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 4 · 2023: 6 · 2022: 2 · 2021: 4 · 2020: 9 · 2019: 14 · 2018: 6 · 2017: 6 · 2016: 7 · 2015: 14 · 2014: 16 · 2013: 15 · 2012: 17
- FWCI
- 1.76
- Type
- journal article
- Language
- en
- Open access
- green
- kclpure.kcl.ac.uk
- Locations
- Biological Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Research Portal (King's College London) (submittedVersion)
- ORCA Online Research @Cardiff (Cardiff University) (submittedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- Funders
- Eli Lilly
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced MRI Techniques and Applications
- Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
- Keywords
- schizophrenia, N-acetylaspartate, 1H NMR, disease stage, prodromal schizophrenia, first-episode schizophrenia, chronic schizophrenia, clinical high risk for psychosis, thalamus, frontal lobe, temporal lobe, neuronal integrity, brain metabolites
- MeSH terms
- Aspartic Acid, Data Interpretation, Statistical, Frontal Lobe, Humans, Magnetic Resonance Spectroscopy, Regression Analysis, Risk, Schizophrenia, Schizophrenic Psychology, Temporal Lobe, Thalamus, Publication Bias, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
